Cardiac muscle function and manipulation
First Claim
Patent Images
1. A method for providing a therapeutic treatment for heart failure in a mammal in need thereof, comprising administering an effective amount of polypeptide consisting of the amino acid sequence of SEQ ID NO:
- 2 to the mammal, wherein the heart failure is associated with cardiomyopathy, hypertension or myocarditis.
1 Assignment
0 Petitions
Accused Products
Abstract
A method of causing cardiomyocyte growth and/or differentiation, the method comprising exposing a cardiomyocyte to neuregulin (NRG) thereby activating the MAP kinase pathway in the cardiomyocyte and causing growth and/or differentiation of the cardiomyocyte. Use of neuregulin, neuregulin polypeptide, neuregulin derivatives, or compounds which mimic the activities of neuregulins in the treatment or management of heart disease and heart failure in a mammal.
-
Citations
51 Claims
-
1. A method for providing a therapeutic treatment for heart failure in a mammal in need thereof, comprising administering an effective amount of polypeptide consisting of the amino acid sequence of SEQ ID NO:
- 2 to the mammal, wherein the heart failure is associated with cardiomyopathy, hypertension or myocarditis.
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)
-
18. A method for providing a therapeutic treatment for heart failure in a mammal in need thereof, comprising administering an effective amount of polypeptide consisting of the amino acid sequence of SEQ ID NO:
- 2 to the mammal, wherein the heart failure is characterized by the heart not pumping blood at the rate needed for the requirements of metabolizing tissues.
- View Dependent Claims (19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34)
- 35. A method for improving cardiac function in a mammal with heart failure, comprising administering an effective amount of polypeptide consisting of the amino acid sequence of SEQ ID NO:
Specification